Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Awards
Help
Project Grant W81XWH2110416
Award Date
8/15/21
Completion Date
2/14/23
Dollars Obligated
$5.9K
Overview
Activity
Transactions
4
Subawards
Federal Agency
Defense Health Agency
Awardee
Xequel Bio, Inc. (T4JKC8B27PJ7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Mt Pleasant, SC 29464, USA
Description
Update #1
GRANEXIN GEL TO TREAT PRESSURE ULCERS
Posted 6/24/21, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
Not listed
GRANEXIN GEL TO TREAT PRESSURE ULCE. DE-OB.
($512k)
1/31/24
Not listed
GRANEXIN GEL TO TREAT PRESSURE ULCERS EXTEND THE PERIOD OF PERFORMANCE UPDATE RECIPIENT NAME AND ADDRESS PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022. THIS MODIFICATION REFLECTS CHANGES CONSISTENT WITH THE TRANSFER TO DHA. 2. DIVISION II HAS BEEN UPDATED TO SUPERSEDE DIVISION III, SUBDIVISION B, PARAGRAPH 18.
$0
11/2/22
Not listed
GRANEXIN GEL TO TREAT PRESSURE ULCERS CHANGE OF PRINCIPAL INVESTIGATOR
$0
1/3/22
Not listed
GRANEXIN GEL TO TREAT PRESSURE ULCERS
$518.0k
6/24/21